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Numerous studies have reported on the roles of genetic factors in the development
of depression in adolescents and young adults. However, there are few systematic
reviews that update our understanding of adolescent depression with the biological
findings identifying the roles of gene expression and/or polymorphism(s). This review
systematically summarized the findings that clearly identified the contribution of a gene to
the risk of depression in adolescents between the ages of 10 and 19 years old and young
adults between the ages of 20 and 25 years old. Data were obtained through searching
PubMed, Embase, and Web of Science. A total of 47 studies on early adolescence
and three studies on young adults were included in the current review. Most articles
studied genes in the serotonergic system (n = 26), dopaminergic system (n = 3), and
the Brain-derived neurotropic factor (BDNF) gene (n = 12). 92.3% of studies (24/26)
identified positive associations of 5-HTTLPR polymorphism with depressive illness or
depressive symptoms. 83.3% of studies (10/12) found positive association between
BDNF Val66Met genotype and adolescent depressive symptoms. More studies should
be conducted on the 18 genes reported in a few studies to clarify their roles in the risk
for adolescent depression.
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INTRODUCTION
Depression is a common disorder affecting an estimated 350 million people worldwide. Long-
lasting depression with moderate or severe intensity is a serious medical condition that can lead
to suicide. An estimated 1 million deaths each year are related to suicide. Although treatments for
depression are effective, fewer than half of all individuals with depression around the world (in
some countries, fewer than 10%) take anti-depressants (WHO, 2014a). Barriers to effective care
include a lack of resources, a lack of trained health care providers, and social stigma associated
with mental disorders (WHO EMRO, 2014). Inaccurate assessment and incorrect diagnosis of
depression in its early stages can also prevent the effective care of individuals with depression. It is
commonly believed that depression is a result of the complex interaction of social, psychological,
and biological factors. Numerous studies have reported the involvement of abnormal gene
expression or single nucleotide polymorphisms (SNPs) of genes in the development of depression
(Bufalino et al., 2013).
Depression is also the leading cause of disability in young people worldwide. An estimated nine
percent of children and adolescents in the US are affected by depression (Dunn et al., 2011).
Although the diagnostic criteria for children and adolescent depression are no different from those
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for adults, one epidemiological study showed that there are
different risk factors for the onset of depression in young
people and in adults (Jaffee et al., 2002). For example,
depressive adolescents experienced more perinatal insults,
caretaker instability, and criminality than adult-onset depressive
patients. Also, depressive adolescents have more behavioral
and socioemotional problems than the adult-onset patients. In
contrast, the adult-onset patients experienced more sexual abuse
in their childhood than depressive adolescents (Jaffee et al., 2002).
Moreover, studies in neuroscience have demonstrated that
adolescence is a special period of development characterized
by significant changes in the structure and connectivity of the
brain, as well as changes in cognition and behavior (Cousins
and Goodyer, 2015). These neurological changes may interplay
between genes and the environment (Paus, 2013). Results from
several family and twin studies suggest that etiologic genetics
do exist in depression during adolescence (Rice, 2009). A few
reviews or meta-analyses have also summarized the gene ×
environment interaction in adolescents with depression (Franic´
et al., 2010; Rice, 2010; Dunn et al., 2011). However, the age
range for adolescence was not accurately defined. Heterogeneity
within a group of depressive patients may be problematic
for the development of theory, research, and treatment of
depressive patients (Jaffee et al., 2002). It is therefore necessary
to summarize the findings in adolescents with an accurately
defined age range: (1) to update the findings on gene expression
or polymorphism in adolescent depression and (2) to evaluate
the value of all genes as a biomarker of adolescent depression.
The WHO defines adolescence as having an age range of 10–19
years old and as a dynamic period with biological, social, and
psychological changes (WHO, 2014b). In this study, the age
range of 10–19 years was defined as adolescence while an age
range of 20–25 years was defined as young adult for analysis.
The goal of the current review is to systematically analyze
studies that tested the role of a gene in the development of
depression or as a risk factor of depression in adolescents.
We focused specifically on the findings and ultimately
provide substantive conclusions on which gene expression
or polymorphism could be a biomarker of depression in
adolescents.
METHODS
Eligibility Criteria
A systematic review of original studies on gene expression
or genetic polymorphisms in adolescents with depression was
conducted. Reports on gene expression or polymorphisms
measured in peripheral blood or postmortem studies in
adolescents were eligible for review. A study was included in
the analysis when: (1) adolescents with depression or depressive
symptoms fell into the range of 10–19 years old (WHO, 2014b)
or young adult at an age of 20–25 years and (2) original research
with the age range and gene being clearly identified. Studies
were excluded if: (1) a study had subjects with age not in
the two age ranges; (2) a study only provided a mean age;
(3) A study contained anxious adolescents only; (4) studies that
were conducted in animals or in vitro; or (5) review or studies
that were not written in English.
Information Sources
Studies were pulled from the electronic databases of PubMed,
Embase, and Web of Science.
Search Strategy
The primary search strategy was carried out using both the
keywords and test words: ‘‘depression’’ and ‘‘adolescent’’ and
‘‘gene’’; ‘‘depression’’ and ‘‘adolescent’’ and ‘‘polymorphism’’;
‘‘depression’’ and ‘‘adolescent’’ and ‘‘genetics’’; ‘‘depression’’
and ‘‘adolescent’’ and ‘‘genetic variants’’; and ‘‘depression’’ and
‘‘adolescent’’ and ‘‘genotype’’.
Data Collection Process
The abstract of each study was screened and the full-text articles
of potentially relevant studies were then retrieved and assessed.
Data were extracted from the retrieved papers by two authors
(LX and SY) independently. Disagreements were resolved by
discussion in a meeting that included several experts from within
the Department. The study selection process was presented in a
flow diagram (Figure 1).
Data Items
Data on age range, study design, demographic characteristics
of patients, and control individuals, gene expression or
polymorphism, tissue type, and the results were extracted.
Outcomes
The association of gene expression or polymorphisms with
disease risk, severity of depressive symptoms, and treatment
outcomes.
Risk of Bias in Individual Studies
Risk of bias was assessed by evaluating choice of study design,
selection of study population, allocation of control individuals,
and quality of assay used.
FIGURE 1 | A flowchart of literature search strategy. A flowchart of the
inclusions and exclusions of studies in the current study.
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Data Synthesis
Data was summarized for each gene including the main
outcomes or conclusion, positive and negative association with
depression.
RESULTS
The literature search identified 1334 articles from PubMed,
EMbase, and Web of Science using the keywords mentioned
above after the removal of duplicates. The end date for the
search is August 29, 2015. The abstracts of the 1334 articles
were screened one by one and articles not written in English,
review articles not for depression in adolescents, comments, and
articles for animal or in vitro studies were excluded from this
study. The studies where the gene name could not be identified
in the abstract were also excluded from further analysis. A
total of 282 studies were finally used for extracting full-length
articles. However, only 261 full-length articles were downloaded
for careful identification. Full-length articles of screening studies,
studies in non-adolescents or with a mixed sample with the age
beyond the range of 10–19 years for adolescents or 20–25 years
for young adults, studies with only the mean age, studies without
clearly identified gene expression or polymorphism, or others
was excluded from the analysis. Finally, 47 full-length articles
(Eley et al., 2004; Mamalakis et al., 2004; Burcescu et al., 2005;
Miraglia del Giudice et al., 2006; Sjöberg et al., 2006; Geng et al.,
2007; Hilt et al., 2007; Pandey et al., 2007, 2012; Feng et al.,
2008; Aslund et al., 2009; Duncan et al., 2009; Goodyer et al.,
2009, 2010; Guo and Tillman, 2009; Laucht et al., 2009; Nilsson
et al., 2009; Nobile et al., 2009; Benjet et al., 2010; Brent et al.,
2010; Mata et al., 2010; Nederhof et al., 2010; Uddin et al., 2010,
2011; Bouma et al., 2011; Hankin et al., 2011; Jenness et al., 2011;
Mata and Gotlib, 2011; Thompson et al., 2011; Chen et al., 2012,
2013; Petersen et al., 2012; Buchmann et al., 2013; Bobadilla et al.,
2013; Comasco et al., 2013; Cutuli et al., 2013; Kohen et al., 2013;
Otten and Engels, 2013; Oppenheimer et al., 2013; Priess-Groben
and Hyde, 2013; Stavrakakis et al., 2013; Banducci et al., 2014;
Cicchetti and Rogosch, 2014; Cruz-Fuentes et al., 2014; Little
et al., 2014; Zhang et al., 2015) in adolescents and three studies
(Hammen et al., 2010; Starr et al., 2013; Thompson et al., 2014)
in young adults were included in this study (Figure 1). The 47
studies in adolescence included 20 genes or gene families while
the three studies in young adults included three genes (Table 1).
Among the studies in early adolescence, only three articles
reported the association between gene expression and depression
in adolescents (Mamalakis et al., 2004; Pandey et al., 2007,
2012) and one study reported a linkage analysis (Feng et al.,
2008). 91.5% (43/47) of articles reported the results of nucleotide
polymorphism analysis of a gene in adolescents with depressive
disease or depressive symptoms (Table 1). Most studies were
related to neurotransmitter receptors and their associated
metabolic enzymes, including the dopaminergic system (DRD2,
DRD4, and COMT) and serotonergic system (serotonin 2A,
5-HTT, MAOA, and TPH). 5-HTT (5-HTTLPR polymorphism)
is the most frequently examined gene (26 articles) followed
by Brain-derived neurotropic factor (BNDF; 12 articles).
Thirteen genes were only reported in one article. Seven genes
(COMT, serotonin 2A, MAOA, estrogen receptor α and β, AR,
glucocorticoid receptor, and adipose polyunsaturated fatty acid
gene) showed no association with depression in adolescents. Four
genes (DRD2, DRD4, TPH1/2, and CREB/CREB1) were reported
by two or three articles with inconsistencies. The 26 studies on
5-HTTLPR contained a total of 14,616 samples, and the 12 studies
on BDNF contained a total of 7646 samples.
Approximately 92.3% (24/26) of studies for the association
between 5-HTTLPR polymorphism and depression in
adolescents yielded a positive outcome (Table 2). Among the 26
studies for 5-HTTLPR polymorphism, 22 studies analyzed the
association between polymorphism and depressive symptoms
(two studies showed negative findings), while four studies
analyzed the role of 5-HTTLPR polymorphism in depression.
Only one study analyzed the association between 5-HTTLPR
polymorphism and the severity of depressive symptoms. It
appears that 5-HTTLPR polymorphism is associated with both
the risk and severity of depression in adolescents. There was
no study to compare the role of 5-HTTLPR polymorphism in
anxiety and depression. The association between 5-HTTLPR
polymorphism and different types of depression (i.e., anxiety vs.
irritability vs. cognitive dysfunction) was not analyzed in this
study because only a few studies analyzed the association between
5-HTTLPR polymorphism and the cognitive dysfunction and the
irritability.
BDNF was the second most frequently studied gene in
adolescents. All 12 studies analyzed the association between
BDNF Val66Met genotype/gene plasticity index and depressive
symptoms. Among them, one study investigated the BDNF
gene plasticity index in adolescents with depressive symptoms
without observing any association. Eleven studies (Hilt et al.,
2007; Duncan et al., 2009; Goodyer et al., 2010; Mata et al., 2010;
Chen et al., 2012, 2013; Buchmann et al., 2013; Comasco et al.,
2013; Stavrakakis et al., 2013; Cicchetti and Rogosch, 2014; Cruz-
Fuentes et al., 2014) investigated the association between the
BDNF Val66Met genotype and adolescent depressive symptoms
with only one study showing no association (Nederhof et al.,
2010; Table 3). However, no study analyzed the association
between BDNF Val66Met genotype and severity of depressive
symptoms. No study compared the role of BDNF Val66Met
genotype in anxiety and depression. The association between
BDNF Val66Met genotype and different types of depression
was not analyzed in this study because no studies analyzed
the BDNF Val66Met genotypes and irritability. Only one study
investigated the association of BDNF Val66Met genotypes with
cognitive dysfunction. Two studies reported the association of
genetic variants in the dopaminergic system with adolescent
depression (Bobadilla et al., 2013; Stavrakakis et al., 2013;
Table 3).
Only three studies investigated the gene polymorphism
and the risk of depression in young adults at an age range
of 20–25 years. Thompson et al. (2014) study found that
OXTR (oxytocin receptor gene) polymorphism influences the
development of depressive symptoms. Starr et al. (2013) study
showed that 5-HTTLPR S-allele can predict relative increases in
probability of depression among boys. Hammen et al. (2010)
study revealed that chronic family stress at age 15 predicted
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TABLE 1 | Summary of literature and outcomes in adolescents.
Gene Reference Measurement Association with
depression
DRD2 Guo and Tillman (2009), Stavrakakis et al. (2013) and
Zhang et al. (2015)
Polymorphism 1 no/2 yes
DRD4 Guo and Tillman (2009), Bobadilla et al. (2013) and
Stavrakakis et al. (2013)
Polymorphism 1 no/2 yes
Catechol-O-methyltransferase (COMT) Stavrakakis et al. (2013) Polymorphism no
Serotonin 2A Stavrakakis et al. (2013) Polymorphism no
Monoamine oxidase A (MAOA) Eley et al. (2004) and Stavrakakis et al. (2013) Polymorphism no
Tryptophan hydroxylase gene (TPH1/2) Nobile et al. (2009), Stavrakakis et al. (2013) and Eley
et al. (2004)
Polymorphism 1 no/2 yes
Serotonin transporter gene (5-HTT) Eley et al. (2004), Sjöberg et al. (2006), Aslund et al.
(2009), Goodyer et al. (2009, 2010), Laucht et al.
(2009), Nobile et al. (2009), Benjet et al. (2010), Uddin
et al. (2010, 2011), Hankin et al. (2011), Jenness et al.
(2011), Mata and Gotlib (2011), Petersen et al. (2012),
Buchmann et al. (2013), Comasco et al. (2013), Cutuli
et al. (2013), Kohen et al. (2013), Oppenheimer et al.
(2013), Otten and Engels (2013), Priess-Groben and
Hyde (2013), Stavrakakis et al. (2013), Banducci et al.
(2014), Cicchetti and Rogosch (2014) and Little et al.
(2014)
Polymorphism 24 yes/2 no
BDNF Hilt et al. (2007), Duncan et al. (2009), Goodyer et al.
(2010), Mata et al. (2010), Nederhof et al. (2010), Chen
et al. (2012, 2013), Buchmann et al. (2013), Comasco
et al. (2013), Stavrakakis et al. (2013), Cicchetti and
Rogosch (2014) and Cruz-Fuentes et al. (2014).
FK506 binding protein 5 (FKBP5) gene Brent et al. (2010) Polymorphism yes
Estrogen receptor α, β Geng et al. (2007) Polymorphism no
Androgen receptor (AR) Geng et al. (2007) Polymorphism no
Glucocorticoid receptor Bouma et al. (2011) Polymorphism no
IL-1β/IL-6/TNF-α Pandey et al. (2012) Expression yes
Neurotrophic tyrosine kinase receptor Feng et al. (2008) Linkage analysis yes
CREB/CREB1 Burcescu et al. (2005) and Pandey et al. (2007) Expression/Polymorphism yes/no
Adipose polyunsaturated fatty acid gene Mamalakis et al. (2004) Expression no
CART Miraglia del Giudice et al. (2006) Polymorphism yes
OXTR Thompson et al. (2011) Polymorphism yes
AP-2β Nilsson et al. (2009) Polymorphism yes
HTR2A/2C Eley et al. (2004) Polymorphism yes
higher depression scores at age 20 among females with one or
two S alleles of 5-HTT gene (Table 4).
Risk of bias was evaluated for the study design, allocation
of control individuals, and quality of assay methods. There
was a wide variation in methods and analysis. Most studies
did not include age or gender-matched control individuals.
Most studies did not provide detailed information about current
medical treatment in the full study sample. Most studies did
not provide observer-based rating scores of depressive symptom
severity.
DISCUSSION
Studies in twins, families, and populations have revealed the
genetic influences on depression (Rice, 2009). Deregulated gene
expression and specific functional genetic polymorphisms have
been demonstrated to be risk factors of depression or to be
associated with the severity of depressive symptoms (Dunn
et al., 2011). Numerous studies have confirmed the existence
of biological etiology in the development and progression of
depression during childhood and adolescence (Dunn et al., 2011;
Paus, 2013; Cousins and Goodyer, 2015). However, the published
reviews did not summarize the up to date biological findings in
only adolescents with defined age ranges. Heterogeneity within
study subjects is a main concern for the research in depressive
patients because the risk factors for the onset of depression in
adolescents and in adults are different. Moreover, the depressive
adolescents may experience more psychopathology, behavioral
and socioemotional problems than adult-depressive patients
(Jaffee et al., 2002). It is therefore important to summarize the
biological findings in depressive patients with a defined age
range. This study updated the genetic findings in adolescent
depression with an age range of 10–19 years defined by WHO
as adolescence and 20–25 years as young adult. This study
demonstrated that genetic polymorphism or expression of 13
genes was associated, but seven tested genes were not associated
with the risk or severity of depression in early adolescence,
while the polymorphism of three genes was associated with the
risk of depression in late adolesence. This review highlighted
the role of several genes or gene families as risk factors
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TABLE 2 | Outcomes of studies on the relationship between 5-HTTLPR and depression in adolescents.
Reference Sample size Main outcomes or conclusion
Stavrakakis et al. (2013) 1196 Adolescents’ depressive symptoms are not modified by 5-HTTLPR
Nobile et al. (2009) 607 Short alleles were associated with higher affective problems scores
Kohen et al. (2013) 192 The s/l vs. l/l genotype showed greater reduction in depression symptoms
Comasco et al. (2013) 1393 5-HTTLPR interacted with unfavorable environment in relation to depressive symptoms
Cutuli et al. (2013) 267 Positive G × E effects on depression were found
Priess-Groben and Hyde (2013) 309 Short allele confers susceptibility to stress for females with depression
Jenness et al. (2011) 200 5-HTTLPR predict depressive symptoms
Otten and Engels (2013) 310 Cannabis use increases the risk of depression only in the presence of 5-HTTLPR short allele genotype
Uddin et al. (2011) 2574 The sl genotype carriers had less higher depressive symptom score
Goodyer et al. (2010) 401 5-HTTLPR short allele modify the risk of a new depressive episode associated with elevated morning
salivary cortisol
Benjet et al. (2010) 78 Short alleles confers vulnerability to depressive symptoms in girls
Goodyer et al. (2009) 403 Episode of depression was increased in those with the “s” allele
Laucht et al. (2009) 309 LL genotype of 5-HTTLPR displayed significantly higher rates of depressive disorders and more
depressive symptoms
Sjöberg et al. (2006) 200 Females carrying the short 5-HTTLPR allele tend to develop depressive symptoms
Nederhof et al. (2010) 1096 Interaction between 5-HTTLPR polymorphism and childhood adversities did not predict depression score
Cicchetti and Rogosch (2014) 1096 G × E interaction of 5-HTTLPR and maltreatment on depression symptoms
Little et al. (2014) 174 Structural abnormalities in the left hippocampus may be partly responsible for an indirect association
between 5-HTTLPR genotype and depressive illness
Banducci et al. (2014) 222 Among girls, but not boys, each copy of the s allele of the 5-HTTLPR was related to increased depressive
symptoms
Buchmann et al. (2013) 259 The carriers of the BDNF Met and 5-HTTLPR s allele are susceptible to depressive symptoms
Oppenheimer et al. (2013) 241 Youth with SS genotype of 5-HTTLPR experienced greatest increases in depressive symptoms when
exposed to elevations in materal symptoms
Petersen et al. (2012) 436 Stress affect adolescents’ likelihood of experiencing depressed symptoms when they have a low
serotonin TE (A/Gmodified5-HTTLPR) genotype
Mata et al. (2010) 50 Girls with homozygous for short 5-HTTLPR allele showed stronger association between depressive and
bulimic symptoms the long allele
Hankin et al. (2011) 220 5-HTTLPR confers susceptibility to depression via stress reactivity
Uddin et al. (2010) 524 5-HTTLPR sl genotype is a risk of depressive symptom in adolescent male
Aslund et al. (2009) 1482 A GxE interaction effect of 5HTTLPR ss allele was found among girls, not boys
Eley et al. (2004) 377 A significant genotype-environmental risk interaction for 5HTTLPR in the risk of depression in girls only
for the development of depression in adolescents. This study
improved our understanding of the etiology of adolescent
depression, and also identified 5-HTTLPR and BDNF Val66Met
polymorphisms as the most studied biomarkers in adolescent
depression.
Low serotonin-receptor levels in the brain have been
widely recognized to be a key cause of depression.
Polymorphisms of the 5-hydroxytryptamine (serotonin)
transporter gene-linked polymorphic region (5-HTTLPR) have
been widely demonstrated to be a risk factor for depression
TABLE 3 | Outcomes of studies on the relationship between BDNF and dopaminergic pathway and depression in adolescents.
Reference Sample size Main outcomes or conclusion
Stavrakakis et al. (2013) 1196 Adolescents’ depressive symptoms are not modified by BDNF
Comasco et al. (2013) 1393 Depressive symptoms and depression were more common among carriers of either the Val/Val or Met genotypes
Goodyer et al. (2010) 401 BDNF (Val66Met) modify the risk of a new depressive episode associated with elevated morning salivary cortisol
Chen et al. (2012) 780 Interaction between BDNF Val66Met polymorphism and environmental stress on depression was observed
Nederhof et al. (2010) 1096 Depression score was not significantly predicted by interaction between BDNF Val66Met polymorphism and
childhood adversities
Mata et al. (2010) 82 BDNF met allele moderate the relation between exercise and depressive symptoms
Duncan et al. (2009) 217 Val/Val genotype correlated with higher levels of depression symptoms
Hilt et al. (2007) 100 Val/Val genotype was associated with more depressive symptoms
Cicchetti and Rogosch (2014) 1096 G × G × E interaction of BDNF, 5-HTTLPR/CRHR1 and maltreatment on depression symptoms
Cruz-Fuentes et al. (2014) 246 Possession of BDNF Met allele was statistically linked with a resilient phenotype of major depression disorder
Buchmann et al. (2013) 259 The carriers of the BDNF Met and 5-HTTLPR s allele are susceptible to depressive symptoms
Chen et al. (2013) 780 BDNF Val allele modulates the influence of environmental stress on depression
Stavrakakis et al. (2013) 1196 Adolescents’ depressive symptoms are not modified by COMT
Guo and Tillman (2009) 2286 DRD2∗304/178 and DRD4∗379/379 genotype are associated with a level of depressive symptoms
Bobadilla et al. (2013) 1882 DRD4 polymorphism is linked to comorbid marijuana use and depression
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TABLE 4 | Summary of literature and outcomes in young adult.
Gene Reference Measurement Association with depression
OXTR Thompson et al. (2014) Polymorphism, n = 441 OXTR influences the development of depressive symptoms
5HTTLRP Starr et al. (2013) Polymorphism, n = 354 S-allele predicts relative increases in probability of depression among boys with low security
5HTT Hammen et al. (2010) Polymorphism, n = 346 Chronic family stress at age 15 predicted higher depression scores at 20 among those
females with one or two S alleles
following adverse life experiences. In this review, a total of 26
articles reported an association between 5-HTTLPR variations
and depression in adolescents. About 92.3% of studies (n = 24)
identified positive associations of 5-HTTLPR polymorphism
with the risk for or susceptibility to depression, new depressive
episodes, and more severe depressive symptoms. The most
commonly examined polymorphism was the 5-HTTLPR variable
number tandem repeat (VNTR), which consists of the s/s,
s/l, and l/l genotypes. In most studies, the short (S) allele
or heterozygote genotype carriers (s/l) of 5-HTTLPR might
experience a greater reduction in depressive symptoms over time
compared with adolescents with the 5-HTTLPR l/l genotype
(Table 2). A recent meta-analysis of the association between the
5-HTTLPR, stress, and the development of depression contained
81 studies with a mean age from 9–77 years. A significant
relationship between the short form of the 5-HTTLPR and
depression was confirmed (p = 0.0000009). However, nearly 26%
of the 81 studies failed to show any significant association, and
four studies even showed opposite results (Sharpley et al., 2014).
Only two studies investigated the 5-HTTLPR polymorphism
and the risk of depression in young adults at an age range of
20–25 years. These two studies showed a positive association
between 5-HTTLPR S-allele and the increased probability of
depression in adolescents (Hammen et al., 2010; Starr et al.,
2013). These findings suggest that 5-HTTLPR polymorphism is
a risk factor for both early onset and late onset depression.
Tryptophan hydroxylase-2 (TPH2) gene has been
acknowledged for many years as the only form of tryptophan
hydroxylase (TPH) responsible for the synthesis of serotonin in
the brain and peripheral tissues. A recent report suggested that
TPH2 gene expression in the dorsal raphe nuclei of depressed
suicidal patients is upregulated [14]. This review included 2
studies on TPH2 in adolescents (Nobile et al., 2009; Stavrakakis
et al., 2013). However, adolescents’ depressive symptoms are not
associated with the gene plasticity index of TPH2 (Stavrakakis
et al., 2013). Monoamine oxidase A is a monoamine oxidase
encoded by the MAOA gene that preferentially deaminates
norepinephrine, epinephrine, serotonin, and dopamine.
Studies in adolescents demonstrated that depressive symptoms
are not associated with gene plasticity index of the MAOA
gene (Stavrakakis et al., 2013), whereas gene × environment
interaction of the 5-HTTLPR was further moderated by MAOA
activity level (Nobile et al., 2009).
BDNF is the most abundant neurotrophin in the mammalian
central nervous system, and reduced BDNF level in the
hippocampus has been revealed to be related to the onset of
depression (Bai et al., 2012). A single nucleotide polymorphism
(SNP) in the BDNF gene (Val66Met) has been shown to
influence the activity of the BDNF protein and cause subsequent
memory impairment and harm avoidance (Jiang et al., 2005).
A significant interaction between BDNF Val66Met and life
stress in depression was widely observed in adults (Hosang
et al., 2014). In this review, the BDNF gene is the second most
frequently studied gene in adolescents with depression. Two
studies on the BDNF gene plasticity index and BDNF level
showed controversial outcomes. The depressive symptoms were
not associated with gene plasticity index of the BDNF gene in
adolescents (Stavrakakis et al., 2013), whereas BDNFmRNA level
correlated with symptom improvement in adult patients with
depression (Cattaneo et al., 2010). Seven studies investigated
the association between BDNF Val66Met polymorphism and
adolescent depression. Two studies showed no association
between BDNF Val66Met polymorphism and depression score,
but 10 studies found significant correlations between BDNF
polymorphism and adolescent depression. A recent meta-
analysis of the interaction between the BDNF Val66Met
polymorphism and stress in depression contained 22 studies
with a mean age range from 8.85–65 years. Results showed that
the Met allele of BDNF Val66Met significantly moderates the
relationship between life stress and depression (p = 0.03; Hosang
et al., 2014). This review only contained three studies with an
age range from 9–19 years. Moreover, a meta analysis of genes
and suicide in 16 studies showed that hypermethylation of BDNF
is associated with individuals that died of suicide (Lockwood
et al., 2015). The involvement of genetic polymorphisms in the
BDNF gene in peripheral tissues of patients with depression may
reflect changes in the BDNF level in their brain. The Val66Met
polymorphism has been demonstrated to impair the packaging
and secretion of BDNF and subsequently reduces hippocampal
volume and impairs memory (Kimpton, 2012; Harrisberger et al.,
2015).
Dopamine is a major neurotransmitter in the central
nervous system, and dysregulation of the dopaminergic-
system is widely reported in people with depression. The
hypofunction of the mesolimbic dopaminergic pathway has
been linked to anhedonia, one of the major symptoms of
depression (Leggio et al., 2013). Studies that directly link genetic
polymorphisms in the dopaminergic pathway to depression
are abundant but show inconsistent findings (Lawford et al.,
2006). For example, Lawford et al study demonstrated that
patients with DRD2∗A1/A2 genotype had significantly higher
depression scores compared to those with the DRD2∗A2/A2
genotype (Lawford et al., 2006). An interaction between DAT1
polymorphism and perceived maternal rejection can influence
the onset of depressive disorder and suicidal ideation (Haeffel
et al., 2008). A significant association between the 48 bp repeat
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polymorphism of DRD4 and depression was reported (Manki
et al., 1996). In contrast, Frisch et al. (1999) found no association
of polymorphisms in DRD4, DAT1, and COMT with depression.
Kirov et al. (1999) found that six dopaminergic genes (DBH,
DAT1, COMT, DRD2, DRD3, and DRD5) played no role in
bipolar disorder. However, the roles of genetic polymorphisms
in the dopaminergic pathway in adolescent depression have
not been summarized. In this study, three studies reported
associations between genetic variants in the dopaminergic system
and adolescent depression (Bobadilla et al., 2013; Stavrakakis
et al., 2013). Significant associations between DRD2, DRD4, and
COMT polymorphisms and the risk of depression, as well as the
severity of depressive symptoms, were reported.
Selective serotonin reuptake inhibitors (SSRIs) are the first
line treatment for depression in the clinic. These inhibitors work
by increasing serotonin levels in the brain to counteract the
low serotonin-receptor levels. A meta-analysis has demonstrated
that the 5-HTTLPR long-allele carriers had higher probability
of response than patients with short-allele homozygotes of
5-HTTLPR with heterogeneity effect (Serretti et al., 2007). No
study investigated the effect of 5-HTTLPR polymorphism on the
efficacy of SSRIs treatment at an age range from 9–19 years.
Rotberg et al. (2013) study in 83 children and adolescents
aged 7–18 years showed that the 5-HTTLPR ss genotype was
associated with a poorer clinical response to citalopram with
regards to depressive symptoms. A recent meta analysis showed
that the BDNF Met carriers had a better response rate to
SSRI than Val/Val, while Met/Val carriers had a weak effect of
response to SSRIs than Val/Val carriers (Yan et al., 2014). Based
on the report from Hammen et al. (2010) study that patients
younger than 18 years old have an increased risk of suicidal
thoughts or behaviors (4% with SSRIs vs. 2% with placebo) with
an antidepressant (Gordon andMelvin, 2013), FDA suggests that
adolescents taking SSRIs must be closely monitored to reduce the
risk for suicide. However, the risk is small and the risk hasn’t
been replicated very well in studies of adolescent depression
treated with SSRIs. For example, Hetrick et al. (2012) study
showed that no significant increase in suicide-related outcomes
was observed in children and adolescents after using individual
SSRIs, such as paroxetine, fluoxetine, sertraline, citalopram, and
escitalopram.
In conclusion, there are more published positive associations
between the genetic polymorphisms in the serotoninergic system,
dopaminergic system, and the Val66Met polymorphism of
BDNF with adolescent depression. However, some biases should
be considered: (1) the publication bias for positive findings;
(2) numerous negative findings may be unpublished; (3) a bias
for investigations of these three polymorphisms first because
of the high profile papers that brought them to attention; and
(4) the polymorphisms can be easily genotyped. Although the
expression or polymorphism of 18 genes has been reported
to be or not be associated with the risk of depression, they
were reported by only a few studies. Therefore, further studies
are needed to accurately identify their roles in depression in
adolescents.
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